Gene · 2303
Papers2,402
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,402
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Adipose-derived exosomal miR-421 targets CBX7 and promotes metastatic potential in ovarian cancer cells. | J Ovarian Res | 2023 | 38037081 | PubTator, text mining | PubMed |
| Role of long-chain polyunsaturated fatty acids, eicosapentaenoic and docosahexaenoic, in the regulation of gene expression during the development of obesity: a systematic review. | Front Nutr | 2023 | 38024342 | PubTator, text mining | PubMed |
| Identification of a Prognostic Gene Signature Based on Lipid Metabolism-Related Genes in Esophageal Squamous Cell Carcinoma. | Pharmgenomics Pers Med | 2023 | 38023824 | PubTator, text mining | PubMed |
| Profound and selective lymphopaenia in primary lymphatic anomaly patients demonstrates the significance of lymphatic-lymphocyte interactions. | Front Immunol | 2023 | 38022535 | PubTator, text mining | PubMed |
| Oxidative stress regulation and related metabolic pathways in epithelial-mesenchymal transition of breast cancer stem cells. | Stem Cell Res Ther | 2023 | 38017510 | PubTator, text mining | PubMed |
| Identification of bladder cancer subtypes and predictive model for prognosis, immune features, and immunotherapy based on neutrophil extracellular trap-related genes. | Sci Rep | 2023 | 38012244 | PubTator, text mining | PubMed |
| Role of epithelial-mesenchymal transition factor SNAI1 and its targets in ovarian cancer aggressiveness. | J Cancer Metastasis Treat | 2023 | 38009093 | PubTator, text mining | PubMed |
| Doxorubicin as a Potential Treatment Option in Canine Mammary Tumors. | Vet Sci | 2023 | 37999477 | PubTator, text mining | PubMed |
| Advances in photoacoustic imaging aided by nano contrast agents: special focus on role of lymphatic system imaging for cancer theranostics. | J Nanobiotechnology | 2023 | 37986071 | PubTator, text mining | PubMed |
| Loss of p53-DREAM-mediated repression of cell cycle genes as a driver of lymph node metastasis in head and neck cancer. | Genome Med | 2023 | 37978395 | PubTator, text mining | PubMed |
| The role of genetic and epigenetic factors in determining the risk of spinal fragility fractures: new insights in the management of spinal osteoporosis. | Quant Imaging Med Surg | 2023 | 37969626 | PubTator, text mining | PubMed |
| Whole-exome sequencing revealed novel genetic alterations in patients with tetralogy of Fallot. | Transl Pediatr | 2023 | 37969115 | PubTator, text mining | PubMed |
| The BET degrader ZBC260 suppresses stemness and tumorigenesis and promotes differentiation in triple-negative breast cancer by disrupting inflammatory signaling. | Breast Cancer Res | 2023 | 37968653 | PubTator, text mining | PubMed |
| A Novel Molecular Classification Method for Glioblastoma Based on Tumor Cell Differentiation Trajectories. | Stem Cells Int | 2023 | 37964983 | PubTator, text mining | PubMed |
| Organ-Specificity of Breast Cancer Metastasis. | Int J Mol Sci | 2023 | 37958607 | PubTator, text mining | PubMed |
| Efficient derivation of transgene-free porcine induced pluripotent stem cells enables in vitro modeling of species-specific developmental timing. | Stem Cell Reports | 2023 | 37949072 | PubTator, text mining | PubMed |
| Multiomic Characterization Reveals a Distinct Molecular Landscape in Young-Onset Pancreatic Cancer. | JCO Precis Oncol | 2023 | 37944072 | PubTator, text mining | PubMed |
| Microbiota in cancer: molecular mechanisms and therapeutic interventions. | MedComm (2020) | 2023 | 37937304 | PubTator, text mining | PubMed |
| The possible dual role of Ang-2 in the prognosis of pancreatic cancer. | Sci Rep | 2023 | 37907568 | PubTator, text mining | PubMed |
| Response of lymphatic endothelial cells to combined spatial and temporal variations in fluid flow. | FASEB J | 2023 | 37902497 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2303/papers?page=7